<?xml version="1.0" encoding="UTF-8" standalone="yes" ?>
<rss version="2.0">
    <channel>
        <title>Symyx Molecular Connection</title>
        <language>en-us</language>
        <description>Get the latest articles from Molecular Connection, our magazine for customers. Stay current with customer stories and workflow solutions utilizing Symyx products and services.
		</description>
        <link>http://www.mdl.com/company/news/newsmagazine/toc.jsp</link>
        <item>
            <title>Calculator add-ins to Symyx Draw</title>
            <description>Symyx Technologies and ACD/Labs are working together to build a series of Symyx Draw add-ins that will enable scientists to calculate molecular properties and assess spectroscopic parameters with Isentris.</description>
            <link>http://www.mdl.com/products/pdfs/scientific_calculators_reprint.pdf</link>
        </item>
        <item>
            <title>Improving inventory management at Dainippon Sumitomo Pharma</title>
            <description>Looking for ways to improve R&amp;D productivity, Dainippon Sumitomo Pharma Co., Ltd (DSP) decided to simplify their stocktaking and inventory management processes. They needed to contain costs by reducing duplicate purchases while simultaneously ensuring that they were meeting strict inventory control, compliance and safety regulations. As a result, DSP set about investigating a replacement for their current reagent sourcing and management system. DSP presented a request for proposal to several software vendors and selected the Symyx Logistics reagent management and procurement system.</description>
            <link>http://www.mdl.com/products/pdfs/dainippon_sumitomo_logistics_reprint.pdf</link>
        </item>
        <item>
            <title>Pharmacological profiling at Spain's CNIO</title>
            <description>Researchers can eliminate undesirable leads early in the lead generation process by quickly accessing information on pharmacological effects, side effects and drug-drug interactions for compounds or compound classes of interest, as well as their corresponding metabolites. The DiscoveryGate online platform supports this timely drug assessment by providing researchers with quick access to a wealth of information, all from within the same system, from data sources which are otherwise dispersed.</description>
			<link>http://www.mdl.com/products/pdfs/cnio_reprint.pdf</link>        
        </item>
        <item>
            <title>Syngene International adopts DiscoveryGate</title>
            <description>Bangalore-based Syngene International Private Limited (a Biocon Company) has recently licensed the DiscoveryGate content platform including CrossFire Beilstein, Patent Chemistry Database, Symyx Available Chemicals Directory (Symyx ACD) and many more. "Through DiscoveryGate, Syngene researchers can easily access a much wider selection of chemistry, chemical sourcing, bioactivity and synthetic methodology databases through a single interface. This cuts costs by reducing in-house database maintenance and improves productivity by making it easier to cross-reference data from multiple sources and make decisions based on all available data," commented Sanjay Sanghani, Symyx's Country Manager in India.</description>
            <link>http://www.mdl.com/products/pdfs/syngene_discoverygate_reprint.pdf</link>
        </item>
        <item>
            <title>Using DiscoveryGate to investigate the pharmacological effects of cholesterol inhibitors</title>
            <description>Hypolipidemic agents are used to lower blood cholesterol when this is elevated(hypercholesterolemia), especially in patients at risk for cardiovascular disease. Subclasses are the statins, fibrates, niacin and the bile acid sequestrants. But what is known about the efficacy of hypolipidemic agents and their side effects? The DiscoveryGate content platform provides quick access to a wealth of information from
			a range of data sources, delivering more structure, bioactivity, synthesis and sourcing information than any other online resource.</description>
            <link>http://www.mdl.com/products/pdfs/using_discoverygate_reprint.pdf</link>
        </item>
	</channel>
</rss>
